24 HR ruxolitinib 22 MG Extended Release Oral Tablet [Jakafi]

RxNorm concept 2743022, branded drug (sbd). Prescribable name: Jakafi XR 22 MG 24HR Extended Release Oral Tablet.

RxCUI: 2743022
Term type: Branded drug (SBD)
Status: Active

Request

curl https://api.healthcare.dev/v1/drugs/rxnorm/2743022 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Concept

Ingredients and related concepts

Ingredients

ruxolitinib 1193326

Other names

Jakafi XR 22 MG 24 HR Extended Release Oral Tablet

Related concepts

ruxolitinib 22 MG (SCDC, consists of)
ruxolitinib 22 MG [Jakafi] (SBDC, consists of)
Extended Release Oral Tablet (DF, has dose form)
Jakafi (BN, has ingredient)
24 HR ruxolitinib 22 MG Extended Release Oral Tablet (SCD, tradename of)

Linked data

NDCs

50881002208

NDC-11s RxNorm links to this concept; linked ones open their FDA product.

Use it

Look up 2743022 from code or an agent

curl

curl https://api.healthcare.dev/v1/drugs/rxnorm/2743022 \
  -H "Authorization: Bearer $HDEV_API_KEY"

MCP prompt

Using the healthcare.dev MCP server, look up RxNorm concept 2743022. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.

Get a free key RxNorm docs Connect the MCP server

Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.